Deal

OXYERA - DIGITAL INNOVATION IN HEALTHCARE

OPPORTUNITY DESCRIPTION

Deal Description

An innovative startup, founded by experts in digitalization technologies for pharmaceutical services and the healthcare ecosystem, AI, and Human-centered computing, has developed an innovative centralized system for the purchase and management of medications, connecting pharmacies, citizens, Residential care homes (RSA), and private clinics.

The innovative elements featuring the startup are:

  • App dedicated to citizens, available for download on the Apple Store and Google Play, allowing users to purchase medications, with or without a prescription, from their chosen pharmacy at the best price available on the market, with either in-store pickup or home delivery options.
  • Innovative portal for pharmacies, optimizing online sales, providing advanced analytical tools, and integrating home delivery services.
  • Software platform for Residential care homes (RSA) that provides direct access to a network of pharmacies offering the best prices and always available medications.
  • Portal for private clinics that enables digital management of prescriptions, online appointment scheduling, and allows patients to directly order medications from the clinic.
  • Business Model: sustainable, scalable, and profitable, based on commissions from orders received through the app, commissions from orders placed by pharmacies, and subscriptions from nursing homes and clinics.

 

Main features

Company size : Start up
Business Model WIN/WIN; Sustainable, scalable, and profitable model based on product purchase/sale commissions and annual subscriptions.
Market presence : Excellent
Number of employees : Below 15 employes
Future potential : Further development of the software and the platform, acquisition of new clients and annual subscriptions, expansion into new markets, and internationalization.
Distribution channels Software platform - social media - Marketing campaigns

Financial data

Revenue : € 0 - 500K
EBITDA Margin < 5%

Potential Target Buyers

Target type : Healthcare
Deal type Sviluppo del progetto anche tramite apporti di equity fino a 100K (1° round) e fino a 650K (2° round), da utilizzare per sviluppo software, marketing, HR ed internazionalizzazione. BENEFICI FISCALI PER INVESTITORI.
Partners type Chemical-Pharmaceutical Industry, Insurance Sector, Healthcare Sector
Sector : Healthcare - Chemicals - Pharmaceuticals -
Are you interested in this deal? Contact us!

Advisory

  • M&A
  • Private equity, club deals and co-investment transactions
  • Corporate advisory and valuations
  • Startups and Businesses development
  • Advisory, Family office, Icon, Heritage & Trophy Real Estate and Wealth management
  • Brokerage of businesses, services and professional activities